Parkwoods Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Parkwoods Wealth Partners's LLY Position: Q2 2026 in Review
Parkwoods Wealth Partners increased its Eli Lilly (LLY) stake by 31% in Q2 2026, buying an estimated $602K and bringing the position to 2,513 shares worth $3.01M. The position accounts for 0.48% of the portfolio, ranked #36.
Parkwoods Wealth Partners first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Parkwoods Wealth Partners held 2,513 shares of Eli Lilly worth $3.01M as of Q2 2026.
- Parkwoods Wealth Partners bought 589 Eli Lilly shares in Q2 2026, an estimated $602K.
- Eli Lilly made up 0.48% of Parkwoods Wealth Partners's portfolio in Q2 2026, its #36 holding.
- Parkwoods Wealth Partners first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Parkwoods Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.